RCM

RA Capital Management Portfolio holdings

AUM $5.94B
This Quarter Return
-11.23%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$696M
AUM Growth
+$696M
Cap. Flow
-$44.9M
Cap. Flow %
-6.45%
Top 10 Hldgs %
54.99%
Holding
75
New
17
Increased
7
Reduced
15
Closed
28

Top Buys

1
ZGNX
Zogenix, Inc.
ZGNX
$22.7M
2
NGNE icon
Neurogene
NGNE
$21.6M
3
AIMT
Aimmune Therapeutics, Inc.
AIMT
$20M
4
GBT
Global Blood Therapeutics, Inc.
GBT
$19.3M
5
ITCI
Intra-Cellular Therapies Inc.
ITCI
$12.6M

Top Sells

1
MDCO
Medicines Co
MDCO
$20.2M
2
DVAX icon
Dynavax Technologies
DVAX
$17.9M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
$16.1M
4
JUNO
Juno Therapeutics, Inc.
JUNO
$14.9M
5
AGEN
Agenus
AGEN
$13.8M

Sector Composition

1 Healthcare 85.07%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
JUNO
51
DELISTED
Juno Therapeutics, Inc.
JUNO
– –
-280,000
Closed -$14.9M
KERX
52
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-59,200
Closed -$591K
TSRO
53
DELISTED
TESARO, Inc.
TSRO
– –
-23,500
Closed -$1.38M
ARRY
54
DELISTED
Array Biopharma Inc
ARRY
– –
-126,095
Closed -$909K
MDCO
55
DELISTED
Medicines Co
MDCO
– –
-705,925
Closed -$20.2M
CLVS
56
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-13,200
Closed -$1.16M
CNCE
57
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-668,406
Closed -$9.95M
TTOO
58
DELISTED
T2 Biosystems, Inc
TTOO
– –
-28
Closed -$2.24M
TRVN
59
DELISTED
Trevena, Inc.
TRVN
– –
-845
Closed -$3.31M
LUMO
60
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
– –
-3,333
Closed -$1.33M
VXRT
61
DELISTED
Vaxart
VXRT
– –
-73,441
Closed -$1.67M
REGN icon
62
Regeneron Pharmaceuticals
REGN
$59.8B
– –
-2,450
Closed -$1.25M
PTCT icon
63
PTC Therapeutics
PTCT
$4.41B
– –
-25,800
Closed -$1.24M
PBYI icon
64
Puma Biotechnology
PBYI
$258M
– –
-3,100
Closed -$362K
OMER icon
65
Omeros
OMER
$284M
– –
-749,000
Closed -$13.5M
NBIX icon
66
Neurocrine Biosciences
NBIX
$13.5B
– –
-24,400
Closed -$1.17M
INCY icon
67
Incyte
INCY
$17B
– –
-10,700
Closed -$1.12M
DVAX icon
68
Dynavax Technologies
DVAX
$1.19B
– –
-766,000
Closed -$17.9M
BIIB icon
69
Biogen
BIIB
$20.8B
– –
-2,600
Closed -$1.05M
AUPH icon
70
Aurinia Pharmaceuticals
AUPH
$1.58B
– –
-1,142,676
Closed -$3.45M
AMGN icon
71
Amgen
AMGN
$153B
– –
-5,900
Closed -$906K
ALKS icon
72
Alkermes
ALKS
$4.95B
– –
-19,200
Closed -$1.24M
AGIO icon
73
Agios Pharmaceuticals
AGIO
$2.36B
– –
-9,900
Closed -$1.1M
AGEN
74
Agenus
AGEN
$136M
– –
-81,520
Closed -$13.8M
ACAD icon
75
Acadia Pharmaceuticals
ACAD
$4.34B
– –
-27,300
Closed -$1.14M
1 2
3